No Data
The U.S. bioterrorism law has undergone significant changes, the CRO concept has launched a major counterattack, and WuXi AppTec is excited!
Industry pessimistic expectations may improve.
How to break through the challenges in the development of innovative drugs? The industry suggests focusing on internationalization.
① The year 2024 will be the inaugural year of large-scale authorized trade, and going abroad has become an important direction for the development of local pharmaceutical companies; ② Chinese企业品牌, clinical trial capabilities, data presentation formats, and levels of international operation still need time and practical verification.
The world's first active sperm detection device is on the market! Beacon Medical-B (2170.HK) Smart Sperm Analyzer is expected to replace the traditional CASA diagnostic mode!
On November 4, 2024, Suzhou, china / PRNewswire/ -- According to the latest data from the National Health Commission's Department of Maternal and Child Health, there are currently 602 medical institutions nationwide that have been approved to carry out human assisted reproduction technology, and the number of IVF institutions globally continues to increase. These institutions, in terms of sperm testing technology, mainly use computer-assisted sperm analysis (CASA) methods to analyze sperm quantity, vitality, morphology, and other indicators based on the guidelines of the fifth edition of the World Health Organization (WHO). From the demand side, the decline in sperm quality among Chinese men has become a confirmed fact. A Frost & Sullivan report pointed out that Chinese men have
Express News | Suzhou Basecare Medical - Jiangsu Mpa Approval of Registration Application for Sperm Quality Analyzer
Suzhou Basecare Medical PGT-A Kit Registration Certificate Renewed for Five Years
Beacon Medical-B (02170.HK): The PGT-A test kit medical instruments registration certificate has been approved for renewal by the National Medical Products Administration.
Gelonghui October 23rd | Beckon Medical-B (02170.HK) announced that the company's independently developed PGT-A test kit for medical instruments, the registration certificate (registration number: National Medical Device Registration Standard 20203400181), was successfully renewed in October 2024 and approved for another five years until February 20, 2030, by the National Medical Products Administration ("NMPA"). In February 2020, the company's PGT-A test kit obtained the first domestic Class III medical device registration certificate with special approval for innovative medical instruments. This test kit is based on high-throughput sequencing technology.
No Data
